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Severe Acute Rejection after Intestinal Transplantation
Without Liver Graft

A Multicenter Evaluation of the Diagnosis, Management
and Outcomes of Adenovirus Enteritis Infection Following
Intestine or Multivisceral Transplant

Moon J1, Iyer K1
1
Mount Sinai Medical Center

Downloaded from http://journals.lww.com/transplantjournal by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AWnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC1y0abggQZXdgGj2MwlZLeI= on 08/25/2021

Introduction: Severe acute rejection (sAR) is one of the most refractory
problems after intestinal transplantation (ITX). Unfortunately there is no effective treatment for sAR. Therefore understanding sAR and developing effective management strategies are critical.
Materials: We reviewed prospectively maintained database at a single center
to describe characteristics of sAR and identify possible factors impacting on
outcome. Study group included consecutive ITX between 2012 and 2020
without liver graft.
Results: There were 78 ITX without liver graft in 70 patients during the study
period. Twenty one sAR were observed in 16 patients, which resulted in 11
graft losses. Incidence of sAR was 23% (16/70). Graft failure rate in sAR
was 52% (11/21). Five patients died as a consequence of sAR. All 6 survivors underwent graft enterectomy and 5 had successful second ITX. Eight
sAR were observed during the first year after ITX and 3 to 4 sAR occurred
annually for the remaining follow-up period. Outcome of sAR was unaffected by Sex, ABO, cytomegalovirus or human leukocyte antigen match
between donor and recipient; onset time of sAR; presence of stoma at the
time of sAR; re-ITX; cross match at the time of ITX; calculated panel reactive antibody or donor specific antibody (DSA) at the time of sAR diagnosis.
Advanced hepatic fibrosis with abnormal total bilirubin (>1.3 mg/dL) and poor
renal function (GFR < 100 ml/min/1.73m2) showed correlation with graft loss
(p=0.072, 0.038, respectively).
Conclusions: sAR is a significant cause of graft loss and death after ITX.
sAR develops frequently in the first year after ITX but also occurs during long
term follow-up. Liver and kidney function at the time of sAR diagnosis seem
to correlate but no clear risk factors predicts outcome of sAR. Second ITX for
the patients who lost graft due to sAR is a viable option. Graft enterectomy
is essential to avoid mortality related sAR when performed timely manner in
selected patients.
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Introduction: Adenovirus Enteritis (AE) is a unique infection which can
complicate patient course following intestine and multivisceral transplantation. Solid organ transplant patients have an increased risk for infection and
intestine and multivisceral patients are unique in that they often develop
inflammation from rejection in the intestine which might predispose to
infection.
Methods: We reviewed patients who received an intestine transplant at three
academic transplant centers between 2010 and 2020 for demographic, laboratory and clinical data.
Results: Five patients were identified with diagnosis of adenovirus enteritis.
Three patients (60%) had isolated intestine transplant while two underwent
multivisceral transplantation. Reason for transplant included trauma, volvulus, intestinal atresia and visceral neuropathy. All patients received induction with anti-thymocyte globulin (80%) or basiliximab. The initial diagnosis of
infection occurred at a mean of 26.8 months following transplant (range 2-68
months). Diagnosis was by polymerase chain reaction (PCR) measurement
in plasma (80%), intestine or stool. Cidofovir was used in 100% of cases as
primary management. 40% of patients had reduction of immunosuppression at the time of diagnosis while the remainder did not. 60% of patients
had rejection within a month prior to diagnosis. No patients had recurrent
rejection in the month following treatment. Two patients had recurrent infection. No patients had graft loss or death within 6 months of infection. Two
patients had enterectomy at a mean of 29.5 months after infection (range
22-37 months) Three patients died at a mean of 32 months following diagnosis (range 8-51 months).
Conclusion: We present a series of five cases of adult patients with AE
following intestinal and multivisceral transplant. AE may arise due to immunosuppression, vascular compromise of the transplanted organ, or a combination of factors. Our study supported rejection as a risk factor for infection.
Graft loss or death was not seen within 6 months following infection.

